Proton pump inhibitors decrease diversity in gut microbiome, increase risk for complications

People who regularly take proton pump inhibitors (PPIs) have less diversity among their gut bacteria, putting them at increased risk for infections like clostridium difficile and pneumonia, in addition to vitamin deficiencies and bone fractures, a new study has shown.